Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution.

Before that happens, you need to see the details here.

John Carey Biography and Net Worth

VP of TransMedics Group

Currently, John F. Carey occupies the position of Vice President-Operations of TransMedics Group, Inc. and Vice President-Operations at TransMedics, Inc. (a subsidiary of TransMedics Group, Inc.).

He previously held the position of Vice President-Operations for Vasca, Inc., Principal at Galileo Electro-Optics Corp. and Principal at C. R. Bard, Inc. (New Jersey).

John F. Carey received an undergraduate degree from the University of Massachusetts.

What is John F. Carey's net worth?: The estimated net worth of John F. Carey is at least $871,204.00 as of January 17th, 2023. Mr. Carey owns 14,120 shares of TransMedics Group stock worth more than $871,204 as of December 21st. This net worth estimate does not reflect any other assets that Mr. Carey may own. Learn More about John F. Carey's net worth.
How do I contact John F. Carey?: The corporate mailing address for Mr. Carey and other TransMedics Group executives is 200 MINUTEMAN ROAD SUITE 302, ANDOVER MA, 01810. TransMedics Group can also be reached via phone at (978) 552-0900 and via email at [email protected]. Learn More on John F. Carey's contact information.
Has John F. Carey been buying or selling shares of TransMedics Group?: John F. Carey has not been actively trading shares of TransMedics Group within the last three months. Most recently, John F. Carey sold 1,410 shares of the business's stock in a transaction on Tuesday, January 17th. The shares were sold at an average price of $62.71, for a transaction totalling $88,421.10. Following the completion of the sale, the vice president now directly owns 14,120 shares of the company's stock, valued at $885,465.20. Learn More on John F. Carey's trading history.
Who are TransMedics Group's active insiders?: TransMedics Group's insider roster includes John Carey (VP), Nicholas Corcoran (Insider), Laura Damme (VP), Stephen Gordon (CFO), Waleed Hassanein (CEO), Edwin Kania, Jr. (Director), Tamer Khayal (Insider), Miriam Provost (VP), and Anil Ranganath (Insider). Learn More on TransMedics Group's active insiders.
Are insiders buying or selling shares of TransMedics Group?: In the last year, insiders at the sold shares 44 times. They sold a total of 464,817 shares worth more than $52,965,578.65. The most recent insider tranaction occured on December, 2nd when insider Tamer I Khayal sold 1,084 shares worth more than $93,657.60. Insiders at TransMedics Group own 7.0% of the company. Learn More about insider trades at TransMedics Group.
Information on this page was last updated on 12/2/2024.

John F. Carey Insider Trading History at TransMedics Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/17/2023	Sell	1,410	$62.71	$88,421.10	14,120
12/2/2022	Sell	10,000	$63.50	$635,000.00	13,808
11/1/2022	Sell	3,000	$49.03	$147,090.00	771
10/3/2022	Sell	3,000	$42.09	$126,270.00	771
8/1/2022	Sell	3,000	$41.27	$123,810.00	771
7/29/2022	Sell	4,000	$40.01	$160,040.00	771
7/20/2022	Sell	1,500	$34.57	$51,855.00	379
7/11/2022	Sell	1,500	$32.98	$49,470.00	379
6/27/2022	Sell	3,320	$32.59	$108,198.80	379
6/24/2022	Sell	2,956	$32.57	$96,276.92	379
6/1/2022	Sell	1,500	$28.19	$42,285.00	379
5/4/2022	Sell	1,500	$25.31	$37,965.00	379
4/1/2022	Sell	1,500	$26.85	$40,275.00	379
3/28/2022	Sell	4,500	$25.01	$112,545.00
11/1/2021	Sell	1,680	$28.16	$47,308.80
10/1/2021	Sell	1,680	$32.33	$54,314.40
9/1/2021	Sell	1,680	$31.98	$53,726.40
7/1/2021	Sell	1,680	$33.65	$56,532.00
5/3/2021	Sell	1,680	$28.34	$47,611.20	702
4/5/2021	Sell	3,360	$36.87	$123,883.20	3,360
3/11/2021	Sell	3,200	$37.50	$120,000.00
9/1/2020	Sell	2,000	$17.59	$35,180.00	5,200
8/3/2020	Sell	2,000	$18.61	$37,220.00	5,200
7/1/2020	Sell	2,000	$17.09	$34,180.00	4,094
6/1/2020	Sell	2,000	$13.21	$26,420.00	5,200
5/1/2020	Sell	2,000	$17.05	$34,100.00	5,200
4/7/2020	Sell	2,000	$13.10	$26,200.00	5,200

John F. Carey Buying and Selling Activity at TransMedics Group

TransMedics Group Company Overview

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Today's Range

Now: $61.70

$59.72

$62.50

50 Day Range

MA: $88.42

$60.53

$134.24

2 Week Range

Now: $61.70

$59.72

$177.37

Volume

1,595,992 shs

Average Volume

1,055,467 shs

Market Capitalization

$2.07 billion

P/E Ratio

65.64

Dividend Yield

N/A

Beta

2.06

Cackling Kamala hates this company

From DTI | Ad